文献速递妇产影像腹部MR

基于MRI影像组学与临床特征的列线图用于产前预测胎盘植入谱系疾病

MRI-radiomics-clinical-based nomogram for prenatal prediction of the placenta accreta spectrum disorders.
PubMed 文献 · Eur Radiol · 2022-05-19

回顾性收集两个中心156例病理证实胎盘植入谱系疾病(PAS)和115例无PAS孕妇的盆腔MR图像与临床资料,提取横轴位斜T2WI影像组学特征构建列线图。列线图在训练队列AUC 0.89、外部验证队列AUC 0.87,均高于MRI形态学判断,校准良好,可辅助PAS疑似孕妇的产前预测。

要点

  • 基于横轴位斜T2WI提取的影像组学标签含3个PAS相关特征,与PAS存在相关(p<0.001至p=0.001)。
  • 列线图整合影像组学标签、2个产前临床特征和2个MRI形态学表现,训练队列AUC 0.89高于MRI形态学的0.78(p<0.001)。
  • 外部验证队列列线图AUC 0.87高于MRI形态学的0.75(p=0.003),独立验证队列AUC 0.91与0.81相比无显著差异(p=0.09)。

核心结论

  • 基于MRI影像组学与临床特征的列线图在产前预测PAS方面表现稳健,可能作为PAS疑似孕妇治疗决策的辅助方法。

研究设计与样本

  • 回顾性收集两个中心156例病理证实PAS和115例经临床及产前超声检查确定无PAS孕妇的盆腔MR图像与临床资料,分为训练队列133例、独立验证队列57例和外部验证队列81例;从横轴位斜T2加权成像提取影像组学特征,构建影像组学标签及由MRI形态学表现、影像组学特征和产前临床特征组成的列线图,并进行区分度和校准度评估。

关键影像表现/征象

  • 影像组学标签包含3个PAS相关特征,在三个队列中均与PAS存在相关(p<0.001至p=0.001)。
  • 列线图整合影像组学标签、2个产前临床特征和2个MRI形态学表现。
  • PAS孕妇的影像组学评分高于无PAS孕妇。

诊断标准与关键数值

  • 列线图在训练队列AUC 0.89,高于MRI形态学判断PAS的AUC 0.78(p<0.001)。
  • 列线图在外部验证队列AUC 0.87,高于MRI形态学判断的AUC 0.75(p=0.003)。
  • 列线图在独立验证队列AUC 0.91,与MRI形态学判断的AUC 0.81相比无显著差异(p=0.09)。
  • 列线图校准良好。

临床应用与阅片要点

  • 列线图可能作为PAS疑似孕妇治疗决策的辅助方法。
  • 影像组学评分提供基于MRI数据预测PAS可能性的数学公式,PAS孕妇评分高于无PAS孕妇。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate whether an MRI-radiomics-clinical-based nomogram can be used to prenatal predict the placenta accreta spectrum (PAS) disorders.

METHODS: The pelvic MR images and clinical data of 156 pregnant women with pathologic-proved PAS (PAS group) and 115 pregnant women with no PAS (non-PAS group) identified by clinical and prenatal ultrasonic examination were retrospectively collected from two centers. These pregnancies were divided into a training (n = 133), an independent validation (n = 57), and an external validation (n = 81) cohort. Radiomic features were extracted from images of transverse oblique T2-weighted imaging. A radiomics signature was constructed. A nomogram, composed of MRI morphological findings, radiomic features, and prenatal clinical characteristics, was developed. The discrimination and calibration of the nomogram were conducted to assess its performance.

RESULTS: A radiomics signature, including three PAS-related features, was associated with the presence of PAS in the three cohorts (p < 0.001 to p = 0.001). An MRI-radiomics-clinical nomogram incorporating radiomics signature, two prenatal clinical features, and two MRI morphological findings was developed, yielding a higher area under the curve (AUC) than that of the MRI morphological-determined PAS in the training cohort (0.89 vs. 0.78; p < 0.001) and external validation cohort (0.87 vs. 0.75; p = 0.003), while a comparable AUC value in the validation cohort (0.91 vs. 0.81; p = 0.09). The calibration was good.

CONCLUSIONS: An MRI-radiomics-clinical nomogram had a robust performance in antenatal predicting the PAS in pregnancies.

KEY POINTS: • An MRI-radiomics-clinical-based nomogram might serve as an adjunctive approach for the treatment decision-making in pregnancies suspicious of PAS. • The radiomic score provides a mathematical formula that predicts the possibility of PAS by using the MRI data, and pregnant women with PAS had higher radiomic scores than those without PAS.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Peng, Zhang, Liu, et al. MRI-radiomics-clinical-based nomogram for prenatal prediction of the placenta accreta spectrum disorders. Eur Radiol. 2022. PMID: 35587828. doi:10.1007/s00330-022-08821-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。